CIM
EW icon

CIM Investment Management’s Edwards Lifesciences EW Stock Holding History

CIM Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410K Sell
4,533
-446
-9% -$37.4K 0.1% 165
2026
Q1 		$399K Sell
4,979
-22
-0.4% -$1.81K 0.11% 150
2025
Q4 		$426K Hold
5,001
– – 0.11% 146
2025
Q3 		$389K Sell
5,001
-5,122
-51% -$400K 0.11% 152
2025
Q2 		$771K Buy
10,123
+5,053
+100% +$377K 0.15% 132
2025
Q1 		$367K Sell
5,070
-4
-0.1% -$286 0.08% 146
2024
Q4 		$376K Sell
5,074
-25
-0.5% -$1.75K 0.11% 154
2024
Q3 		$336K Sell
5,099
-145
-3% -$10.5K 0.1% 173
2024
Q2 		$484K Sell
5,244
-48
-0.9% -$4.25K 0.15% 129
2024
Q1 		$506K Hold
5,292
– – 0.15% 133
2023
Q4 		$404K Hold
5,292
– – 0.13% 160
2023
Q3 		$367K Sell
5,292
-133
-2% -$10.7K 0.13% 155
2023
Q2 		$512K Buy
5,425
+12
+0.2% +$1.04K 0.17% 118
2023
Q1 		$448K Buy
5,413
+238
+5% +$18.7K 0.17% 130
2022
Q4 		$386K Buy
+5,175
New +$399K 0.15% 137
2022
Q3 		– Sell
-4,637
Closed -$441K – 228
2022
Q2 		$441K Sell
4,637
-42
-0.9% -$4.35K 0.18% 118
2022
Q1 		$551K Sell
4,679
-4
-0.1% -$449 0.19% 110
2021
Q4 		$607K Sell
4,683
-83
-2% -$9.68K 0.18% 121
2021
Q3 		$540K Sell
4,766
-46
-1% -$5.25K 0.17% 126
2021
Q2 		$498K Buy
+4,812
New +$454K 0.15% 142

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CIM Investment Management's EW Position: Q2 2026 in Review

CIM Investment Management reduced its Edwards Lifesciences (EW) stake by 9% in Q2 2026, selling an estimated $37.4K and leaving 4,533 shares worth $410K. The position accounts for 0.1% of the portfolio, ranked #165.

CIM Investment Management first reported a position in EW in Q2 2021 and has held it in 20 quarters since. The position peaked at $771K in Q2 2025. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • CIM Investment Management held 4,533 shares of Edwards Lifesciences worth $410K as of Q2 2026.
  • CIM Investment Management sold 446 Edwards Lifesciences shares in Q2 2026, an estimated $37.4K.
  • Edwards Lifesciences made up 0.1% of CIM Investment Management's portfolio in Q2 2026, its #165 holding.
  • CIM Investment Management first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 20 quarters since.
  • CIM Investment Management's Edwards Lifesciences position peaked at $771K in Q2 2025.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on CIM Investment Management's 13F filing for Q2 2026, filed 29 Sep 2026.